View in EDS HTML Full Text PDF Full Text

Gastric Neoplasm Risk with DPP-4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors: Network Meta-Analysis of Randomized Trials.

Saved in:
Bibliographic Details
Title: Gastric Neoplasm Risk with DPP-4 Inhibitors, GLP-1 Receptor Agonists, and SGLT2 Inhibitors: Network Meta-Analysis of Randomized Trials.
Authors: Hung, Chao-Ming1,2 (AUTHOR), Hsu, Chih-Wei2,3 (AUTHOR), Zeng, Bing-Syuan3,4 (AUTHOR), Suen, Mein-Woei4,5,6,7,8 (AUTHOR), Chen, Jiann-Jy5,9,10 (AUTHOR), Zeng, Bing-Yan6,11,12 (AUTHOR), Carvalho, Andre F.7,13 (AUTHOR), Stubbs, Brendon8,14,15,16 (AUTHOR), Chen, Yen-Wen9 (AUTHOR), Chen, Tien-Yu10,17,18 (AUTHOR), Hsu, Shih-Pin2,11,19 (AUTHOR), Wang, Hung-Yu12,20 (AUTHOR), Liang, Chih-Sung13,21,22 (AUTHOR), Tu, Yu-Kang14,23,24 (AUTHOR) yukangtu@ntu.edu.tw, Tseng, Ping-Tao9,15,25,26 (AUTHOR) ducktseng@gmail.com
Source: International Journal of Molecular Sciences. Mar2026, Vol. 27 Issue 6, p2619. 21p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:16616596
DOI:10.3390/ijms27062619